Cancer drug Avastin doesn’t extend life for newly diagnosed brain tumour patients, studies find
CHICAGO – New research raises fresh questions about which cancer patients benefit from Avastin (uh-VAS’-tihn), a drug that lost its approval for treating breast cancer nearly two years ago.
Two studies found that Avastin did not prolong life when used as a first treatment for people with brain tumors like the one U.S. Sen. Edward Kennedy died of several years ago. Side effects also were more common with Avastin.
The drug is approved for treating brain tumors that have recurred and doctors say it should still be used in those patients.
Other research shows it extends survival for women with advanced cervical cancer. Avastin also is used to treat certain colon, lung and kidney tumors.
The studies were discussed Sunday at a cancer conference in Chicago.
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community? Create a free account to comment on stories, ask questions, and join meaningful discussions on our new site.
Leave a Reply
You must be logged in to post a comment.